- RNAC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-1/A Filing
Cartesian Therapeutics (RNAC) S-1/AIPO registration (amended)
Filed: 8 Jun 16, 12:00am
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 30, 2016 (except for Note 17(b) as to which the date is June 8, 2016) in the Amendment No. 1 to the Registration Statement (Form S-1 No. 333-211555) and related Prospectus of Selecta Biosciences, Inc. for the registration of its common stock.
/s/ Ernst & Young LLP |
|
|
|
Boston, Massachusetts |
|
June 8, 2016 |
|
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.